Proportion of Patients Reaching the Target CD34+ Cell Yield and the Median Number of Leukaphereses Required to Reach the Target Yield for Each Treatment Group
| Treatment Group . | Percentage of Patients Reaching the Target CD34+ Cell Yield . | Median No. of Leukaphereses Required to Reach the Target Yield . | ||
|---|---|---|---|---|
| ITT (n = 203) . | Evaluable (n = 175) . | ITT (n = 203) . | Evaluable (n = 175) . | |
| SCF + Filgrastim | 63 | 67 | 4 | 3 |
| Filgrastim | 47 | 48 | ≥6 | ≥6 |
| P value | <.05 | <.01 | <.05 | <.01 |
| Treatment Group . | Percentage of Patients Reaching the Target CD34+ Cell Yield . | Median No. of Leukaphereses Required to Reach the Target Yield . | ||
|---|---|---|---|---|
| ITT (n = 203) . | Evaluable (n = 175) . | ITT (n = 203) . | Evaluable (n = 175) . | |
| SCF + Filgrastim | 63 | 67 | 4 | 3 |
| Filgrastim | 47 | 48 | ≥6 | ≥6 |
| P value | <.05 | <.01 | <.05 | <.01 |
Abbreviation: ITT, intent-to-treat.